12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Pieris, Daiichi Sankyo deal

Pieris received an undisclosed milestone payment from Daiichi under a 2011 deal to discover Anticalin candidates against two undisclosed targets selected by Daiichi. The payment was triggered by Pieris' delivery of...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >